Published in Clin Lab on January 01, 2003
Anti-obesity activity of the marine carotenoid fucoxanthin. Mar Drugs (2015) 1.00
Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease. Transl Psychiatry (2015) 0.96
Treatment of dyslipidemia in patients with type 2 diabetes. Lipids Health Dis (2010) 0.95
Effect of prebiotic fibre supplementation on hepatic gene expression and serum lipids: a dose-response study in JCR:LA-cp rats. Br J Nutr (2009) 0.94
n-3 Fatty acids decrease arterial low-density lipoprotein cholesterol delivery and lipoprotein lipase levels in insulin-resistant mice. Arterioscler Thromb Vasc Biol (2010) 0.88
Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects. Cardiovasc Diabetol (2013) 0.86
Interactive effects of APOE haplotype, sex, and exercise on postheparin plasma lipase activities. J Appl Physiol (1985) (2011) 0.81
Low-normal thyroid function and novel cardiometabolic biomarkers. Nutrients (2015) 0.81
Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus. Exp Mol Med (2008) 0.80
Osbpl8 deficiency in mouse causes an elevation of high-density lipoproteins and gender-specific alterations of lipid metabolism. PLoS One (2013) 0.78
Lipoprotein subfraction cholesterol distribution is more atherogenic in insulin resistant adolescents with type 1 diabetes. Pediatr Diabetes (2015) 0.77
HDL size is more accurate than HDL cholesterol to predict carotid subclinical atherosclerosis in individuals classified as low cardiovascular risk. PLoS One (2014) 0.75
High fat diet modifies the association of lipoprotein lipase gene polymorphism with high density lipoprotein cholesterol in an Asian Indian population. Nutr Metab (Lond) (2017) 0.75
Reduced first-phase insulin secretion increases postprandial lipidemia in subjects with impaired glucose tolerance. BMJ Open Diabetes Res Care (2017) 0.75
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA (2008) 4.21
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment. Clin J Am Soc Nephrol (2012) 1.78
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. J Clin Endocrinol Metab (2006) 1.75
Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility. Circulation (2010) 1.75
A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. J Am Coll Cardiol (2004) 1.58
111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas. J Nucl Med (2008) 1.21
Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation (2009) 1.20
Radiation optic neuropathy after external beam radiation therapy for acromegaly: report of two cases. Radiother Oncol (2003) 1.11
Radiation optic neuropathy after external beam radiation therapy for acromegaly. Radiother Oncol (2003) 1.08
Lack of radiation optic neuropathy in 72 patients treated for pituitary adenoma. J Neuroophthalmol (2004) 1.07
Associations between smoking, components of metabolic syndrome and lipoprotein particle size. BMC Med (2013) 1.06
Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes (2005) 1.02
Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. J Clin Endocrinol Metab (2007) 1.01
Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease. Arterioscler Thromb Vasc Biol (2012) 0.99
Inflammation reduces HDL protection against primary cardiac risk. Eur J Clin Invest (2010) 0.98
The association of APOE genotype with cognitive function in persons aged 35 years or older. PLoS One (2011) 0.98
Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease. Eur J Clin Invest (2010) 0.98
The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study. Eur J Intern Med (2012) 0.97
Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research. Biomark Med (2013) 0.96
Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol (2014) 0.95
Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease. J Lipid Res (2010) 0.92
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides. Eur Heart J (2007) 0.92
Carotid intima media thickness is related positively to plasma pre ß-high density lipoproteins in non-diabetic subjects. Clin Chim Acta (2011) 0.90
Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging. Eur J Clin Invest (2012) 0.88
Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study. J Clin Endocrinol Metab (2013) 0.88
Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion. Cardiovasc Ther (2010) 0.86
Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. J Clin Endocrinol Metab (2011) 0.86
Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: relationship with lipoprotein response to antiproteinuric treatment. Atherosclerosis (2012) 0.86
The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients. BMC Med Genet (2009) 0.86
Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes. Eur J Clin Invest (2014) 0.85
Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL. Eur J Clin Invest (2011) 0.85
Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus. Atherosclerosis (2011) 0.85
Analysis of cortisol and other stress-related hormones in patients with Ménière's disease. Otol Neurotol (2005) 0.84
Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects. Atherosclerosis (2011) 0.84
Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders. Eur J Clin Invest (2015) 0.83
High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: a nested case-control study. Atherosclerosis (2011) 0.83
Low normal free T4 confers decreased high-density lipoprotein antioxidative functionality in the context of hyperglycaemia. Clin Endocrinol (Oxf) (2013) 0.83
The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides. J Clin Endocrinol Metab (2005) 0.83
Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys (2006) 0.83
Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins. Curr Opin Lipidol (2007) 0.83
Adiposity blunts the positive relationship of thyrotropin with proprotein convertase subtilisin-kexin type 9 levels in euthyroid subjects. Thyroid (2013) 0.82
Cholesterol efflux capacity and atherosclerosis. N Engl J Med (2011) 0.82
Adrenal hemorrhage causing adrenal insufficiency in a patient with antiphospholipid syndrome: increased adrenal 18F-FDG uptake. J Clin Endocrinol Metab (2012) 0.82
Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy. Clin Endocrinol (Oxf) (2011) 0.82
Salt loading affects cortisol metabolism in normotensive subjects: relationships with salt sensitivity. J Clin Endocrinol Metab (2003) 0.82
Low normal thyroid function enhances plasma cholesteryl ester transfer in Type 2 diabetes mellitus. Atherosclerosis (2013) 0.82
Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects. Atherosclerosis (2010) 0.81
LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP. Atherosclerosis (2010) 0.81
Cholesteryl Ester Transfer Protein (CETP) genotype and cognitive function in persons aged 35 years or older. Neurobiol Aging (2012) 0.81
Lipid levels do not influence the risk of venous thromboembolism. Results of a population-based cohort study. Thromb Haemost (2012) 0.81
Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets. Biochim Biophys Acta (2009) 0.81
Reference values for aldosterone-renin ratios in normotensive individuals and effect of changes in dietary sodium consumption. Clin Chem (2011) 0.81
Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio. J Clin Lipidol (2012) 0.80
Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects. Clin Lab (2005) 0.80
Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin beta-subunit and pituitary gonadal hormones. Fertil Steril (2008) 0.80
Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein. Metabolism (2012) 0.80
Hypoglycemia in a patient with a big "big"-IGF-II-producing tumor. J Clin Endocrinol Metab (2013) 0.80
Increased coronary heart disease risk determined by high high-density lipoprotein cholesterol and C-reactive protein: modulation by variation in the CETP gene. Arterioscler Thromb Vasc Biol (2010) 0.79
Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes. Eur J Clin Invest (2011) 0.79
Plasma proprotein convertase subtilisin-kexin type 9 does not change during 24h insulin infusion in healthy subjects and type 2 diabetic patients. Atherosclerosis (2010) 0.79
Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus. Atherosclerosis (2010) 0.79
Angiotensin administration stimulates renal 11 beta-hydroxysteroid dehydrogenase activity in healthy men. Kidney Int (2004) 0.78
Renin-angiotensin-aldosterone responsiveness to low sodium and blood pressure reactivity to angiotensin-II are unrelated to cholesteryl ester transfer protein mass in healthy subjects. Expert Opin Ther Targets (2008) 0.78
Severe hypercortisolism: a medical emergency requiring urgent intervention. Crit Care Med (2010) 0.78
Unilateral and bilateral adrenalectomy for pheochromocytoma requires adjustment of urinary and plasma metanephrine reference ranges. J Clin Endocrinol Metab (2013) 0.78
Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition. Eur J Clin Invest (2012) 0.78
Plasma Lp-PLA(2) mass and apoB-lipoproteins that carry Lp-PLA(2) decrease after sodium. Eur J Clin Invest (2012) 0.77
Salt sensitivity and 11beta-hydroxysteroid dehydrogenase type 2 activity. Am J Hypertens (2004) 0.77
Low-normal free thyroxine confers decreased serum bilirubin in type 2 diabetes mellitus. Thyroid (2013) 0.77
Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial. Neuroendocrinology (2015) 0.77
Relationship of proprotein convertase subtilisin-kexin type 9 levels with resistin in lean and obese subjects. Clin Biochem (2012) 0.77
Repeated [131I]metaiodobenzylguanidine therapy in two patients with malignant pheochromocytoma. J Clin Endocrinol Metab (2005) 0.76
Tyrosine positron emission tomography and protein synthesis rate in pituitary adenoma: different effects of surgery and radiation therapy. Radiother Oncol (2011) 0.76
Cognitive performance after postoperative pituitary radiotherapy: a dosimetric study of the hippocampus and the prefrontal cortex. Eur J Endocrinol (2011) 0.76
Urinary Urea Excretion and Long-term Outcome After Renal Transplantation. Transplantation (2015) 0.76
Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction. Nephrol Dial Transplant (2004) 0.76
Familial occurrence of subacute thyroiditis associated with human leukocyte antigen-B35. Thyroid (2004) 0.76
Dopamine excess in patients with head and neck paragangliomas. Anticancer Res (2010) 0.76
Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein. PLoS One (2012) 0.75
New imaging approaches to phaeochromocytomas and paragangliomas. Clin Endocrinol (Oxf) (2009) 0.75
Cortisol metabolism and glucose intolerance. J Clin Endocrinol Metab (2003) 0.75
Does a reduced 11 beta HSD type 2 activity contribute to sodium retention in the nephrotic syndrome? Nephrol Dial Transplant (2003) 0.75
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo. Clin Endocrinol (Oxf) (2007) 0.75
Diagnostic I-131 scintigraphy in patients with differentiated thyroid cancer: no additional value of higher scan dose. Ann Nucl Med (2004) 0.75
Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment. Nephrol Dial Transplant (2005) 0.75
Better yield of (18)fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation. Thyroid (2002) 0.75
Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue. Neuroendocrinology (2015) 0.75
Dopamine concentration in blood platelets is elevated in patients with head and neck paragangliomas. Clin Chem Lab Med (2016) 0.75
Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9. Arch Med Res (2012) 0.75
Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development. Curr Diab Rep (2008) 0.75
No renal phenotype in human phospholipid transfer protein transgenic apolipoprotein E deficient mice despite severe aortic atherosclerosis. Clin Lab (2014) 0.75
Letter in response to recent paper by Fournier et al. Atherosclerosis (2002) 0.75
Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity. Eur J Intern Med (2012) 0.75
Statin and fibrate combination does not additionally lower plasma cholesteryl ester transfer in type 2 diabetes mellitus. Clin Lab (2012) 0.75